ConductScience.org, home

Paper219129

Regulation of specific cell-mediated cytotoxic response against SV40-induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice.

Glaser M. J Exp Med, 1979. Cited by 123 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Regulation of specific cell-mediated cytotoxic response against SV40-induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice. Papers, record 219129. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/219129

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Regulation of specific cell-mediated cytotoxic response against SV40-induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice.
PubMed
Journal
J Exp Med
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
123
iCite
Relative citation ratio, by iCite
2.95
iCite
Revised in PubMed
2021-12-03
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Glaser MM

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, NeoplasmMajor topic
CyclophosphamideMajor topic
Cytotoxicity, ImmunologicMajor topic
Immunity, CellularMajor topic
Immunosuppression TherapyMajor topic
T-LymphocytesMajor topic
Tumor Virus InfectionsMajor topic
Animals
Antigens, Viral
Cell Transformation, Viral
Female
Mice
Simian virus 40

Source PubMed

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1213,615Specific immune response against tumor-associated antigens of a syngeneic simian virus 40-induced sarcoma in mice.J Natl Cancer Inst1978https://conductscience.org/library/papers/213615PubMed
2142,792Antigen-induced cyclophosphamide-resistant suppressor T cells inhibit the in vitro generation of cytotoxic cells from one-way mixed leukocyte reactions.J Immunol1977https://conductscience.org/library/papers/142792PubMed
3299,883Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes.J Exp Med1977https://conductscience.org/library/papers/299883PubMed
4692,680Cyclophosphamide delays 3-methylcholanthrene sarcoma induction in mice.Nature1978https://conductscience.org/library/papers/692680PubMed
54,116,319The regulatory influence of activated T cells on B cell responses to antigen.Adv Immunol1972https://conductscience.org/library/papers/4116319PubMed
64,129,833Immunogenic properties of a soluble tumor-specific transplantation antigen induced by Simian virus 40.J Natl Cancer Inst1974https://conductscience.org/library/papers/4129833PubMed
74,363,713Cellular immunity in mice with simian virus 40-induced mKSA tumors: comparison of three assays of tumor immunity.J Natl Cancer Inst1974https://conductscience.org/library/papers/4363713PubMed
84,376,531Cell interactions in adoptive immune rejection of a syngeneic tumor.Int J Cancer1974https://conductscience.org/library/papers/4376531PubMed
91,080,165Syngeneic adoptive immunotherapy and chemoimmunotherapy of a Friend leukemia: requirement for T cells.J Immunol1975https://conductscience.org/library/papers/1080165PubMed
104,583,975Enhancement of normal lymphocyte cytotoxicity by sera with high antibody titers against H-2 or virus-associated antigens.Cancer Res1973https://conductscience.org/library/papers/4583975PubMed
114,587,740A rapid method for the isolation of functional thymus-derived murine lymphocytes.Eur J Immunol1973https://conductscience.org/library/papers/4587740PubMed
124,598,645T cell control of antibody production.Contemp Top Immunobiol1974https://conductscience.org/library/papers/4598645PubMed
134,598,017Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide.J Exp Med1974https://conductscience.org/library/papers/4598017PubMed
144,543,478Effect of antibody to theta antigen on cell-mediated immunity induced in syngeneic mice by murine sarcoma virus.J Natl Cancer Inst1973https://conductscience.org/library/papers/4543478PubMed
154,547,522B-cell suppression of delayed hypersensitivity reactions.Nature1974https://conductscience.org/library/papers/4547522PubMed
164,538,884Functional aspects of the selective depletion of lymphoid tissue by cyclophosphamide.Immunology1972https://conductscience.org/library/papers/4538884PubMed
17179,019Cell-mediated cytotoxicity to SV40-specific tumour-associated antigens.Nature1976https://conductscience.org/library/papers/179019PubMed
181,101,472The role of specific suppressor T cells in immune tolerance.Transplant Rev1975https://conductscience.org/library/papers/1101472PubMed
191,101,468Properties of primed suppressor T cells and their products.Transplant Rev1975https://conductscience.org/library/papers/1101468PubMed
201,117,258Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses.J Exp Med1975https://conductscience.org/library/papers/1117258PubMed

See all 21 references

Cited by28

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 123 citations.

PMIDTitleJournalYearIn PapersSource
35,701,637Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities.Nat Rev Drug Discov2022https://conductscience.org/library/papers/35701637PubMed
21,479,313Combination approaches to potentiate immune response after photodynamic therapy for cancer.Photochem Photobiol Sci2011https://conductscience.org/library/papers/21479313PubMed
21,162,652Stimulation of anti-tumor immunity by photodynamic therapy.Expert Rev Clin Immunol2011https://conductscience.org/library/papers/21162652PubMed
18,704,409Combinatorial treatments including vaccines, chemotherapy and monoclonal antibodies for cancer therapy.Cancer Immunol Immunother2009https://conductscience.org/library/papers/18704409PubMed
18,097,448Immunological aspects of cancer chemotherapy.Nat Rev Immunol2008https://conductscience.org/library/papers/18097448PubMed
9,435,316Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.J Clin Invest1998https://conductscience.org/library/papers/9435316PubMed
6,819,082The effects of cyclophosphamide on in vitro cytotoxic responses to a syngeneic tumour.Cancer Immunol Immunother1982https://conductscience.org/library/papers/6819082PubMed
6,788,892Enhancement of delayed hypersensitivity reaction with varieties of anti-cancer drugs. A common biological phenomenon.J Exp Med1981https://conductscience.org/library/papers/6788892PubMed
6,460,831Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells.J Exp Med1982https://conductscience.org/library/papers/6460831PubMed
6,453,350Reduced tumor growth after low-dose irradiation or immunization against blastic suppressor T cells.Proc Natl Acad Sci U S A1981https://conductscience.org/library/papers/6453350PubMed
6,332,673The use of cytotoxic T cells in the regulation of tumour growth in syngeneic mice.Cancer Immunol Immunother1984https://conductscience.org/library/papers/6332673PubMed
6,332,093Evaluation of various cytostatic drugs as local immunotherapeutic agents.Invest New Drugs1984https://conductscience.org/library/papers/6332093PubMed
6,313,694Inverse relationship between anti-SV40 TASA and anti-H-2 cytotoxic responses.J Cancer Res Clin Oncol1983https://conductscience.org/library/papers/6313694PubMed
6,256,760Resistance of simian virus 40-transformed hamster cells to the cytolytic effect of activated macrophages: a possible factor in species-specific viral oncogenicity.Proc Natl Acad Sci U S A1980https://conductscience.org/library/papers/6256760PubMed
6,244,225Cell-mediated immunity against herpes simplex induction of cytotoxic T lymphocytes.Infect Immun1980https://conductscience.org/library/papers/6244225PubMed
6,227,381Suppressor and reactive lymphocytes in radiation leukemia virus (RadLV)-induced leukemogenesis.Cancer Immunol Immunother1983https://conductscience.org/library/papers/6227381PubMed
3,488,127Histological changes in spleen and lymph nodes of mice administered cyclophosphamide and levan.Cell Tissue Res1986https://conductscience.org/library/papers/3488127PubMed
3,230,726A trial of postoperative adjuvant combination chemo-immunotherapy for stage IV gastric carcinoma.Jpn J Surg1988https://conductscience.org/library/papers/3230726PubMed
3,156,616In vivo detection and partial characterization of effector and suppressor cell populations in spleens of mice with large metastatic fibrosarcomas.Br J Cancer1985https://conductscience.org/library/papers/3156616PubMed
2,949,833In vivo resistance of secondary antitumor immune response to cyclophosphamide: effects on T cell subsets.Cancer Immunol Immunother1987https://conductscience.org/library/papers/2949833PubMed

See all 28 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/219129

GET https://conductscience.org/api/papers/v1/219129/references?page=2